Post-Hysterectomy Cystoscopy May Lead to False-Positive Result

Share this content:
Post-Hysterectomy Cystoscopy May Lead to False-Positive Result
Post-Hysterectomy Cystoscopy May Lead to False-Positive Result

MONDAY, Aug. 17, 2015 (HealthDay News) -- For patients with a pre-existing unknown nonfunctional kidney, cystoscopy to confirm ureteral patency after hysterectomy may lead to an incorrect assumption of a ureteral injury, according to a case report published in the September issue of Obstetrics & Gynecology.

Kuhali Kundu, D.O., from Einstein Medical Center in Philadelphia, and colleagues describe two cases in which cystoscopy was performed in patients with a pre-existing unknown nonfunctional kidney to confirm ureteral patency after hysterectomy.

Two cases are presented by the researchers: a 42-year-old woman who underwent an attempted vaginal hysterectomy converted to abdominal hysterectomy and a 35-year-old woman who underwent vaginal hysterectomy. Neither patient underwent preoperative evaluation of the kidneys. Cystoscopy to confirm ureteral patency with intravenous indigo carmine was performed in both cases; there was no efflux of blue-tinted urine from the right ureteral orifice and the patients underwent further exploratory surgery. While the second patient was under anesthesia, discussion with the family revealed that the patient had been diagnosed with a unilateral nonfunctional kidney of unknown etiology as a child. Both patients underwent extensive additional operating room time (three and 3.5 hours, respectively) in addition to radiation exposure.

"Cystoscopy to confirm ureteral patency after hysterectomy may lead to an incorrect presumption of a ureteral injury in patients with a pre-existing nonfunctional kidney," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »